Gene · 406932
Papers3,316
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,316
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNA and Rare Human Diseases. | Genes (Basel) | 2024 | 39457367 | PubTator, text mining | PubMed |
| A novel mesenchymal stem cell-targeting dual-miRNA delivery system based on aptamer-functionalized tetrahedral framework nucleic acids: Application to endogenous regeneration of articular cartilage. | Bioact Mater | 2024 | 39253616 | PubTator, text mining | PubMed |
Exosomes derived from bone marrow mesenchymal stem cell preconditioned by low-intensity pulsed ultrasound stimulation promote bone-tendon interface fibrocartilage regeneration and ameliorate rotator cuff fatty infiltration. | J Orthop Translat | 2024 | 39189009 | PubTator, text mining | PubMed |
| Identification of miRNAs related to osteoporosis by high-throughput sequencing. | Front Pharmacol | 2024 | 39175544 | PubTator, text mining | PubMed |
| Macrophage-derived extracellular vesicles regulate skeletal stem/progenitor Cell lineage fate and bone deterioration in obesity. | Bioact Mater | 2024 | 39072285 | PubTator, text mining | PubMed |
| Dysregulated expression of miR-140 and miR-122 compromised microglial chemotaxis and led to reduced restriction of AD pathology. | J Neuroinflammation | 2024 | 38956605 | PubTator, text mining | PubMed |
| Insight into the Functional Dynamics and Challenges of Exosomes in Pharmaceutical Innovation and Precision Medicine. | Pharmaceutics | 2024 | 38931833 | PubTator, text mining | PubMed |
| Adenovirus 36 seropositivity is related to the expression of anti-adipogenic lncRNAs GAS5 and MEG3 in adipose tissue obtained from subjects with obesity. | Int J Obes (Lond) | 2024 | 38898229 | PubTator, text mining | PubMed |
| Stem-Cell-Driven Chondrogenesis: Perspectives on Amnion-Derived Cells. | Cells | 2024 | 38727280 | PubTator, text mining | PubMed |
| MiR-29 and MiR-140 regulate TRAIL-induced drug tolerance in lung cancer. | Anim Cells Syst (Seoul) | 2024 | 38693921 | PubTator, text mining | PubMed |
| Specific isoforms of the ubiquitin ligase gene WWP2 are targets of osteoarthritis genetic risk via a differentially methylated DNA sequence. | Arthritis Res Ther | 2024 | 38570801 | PubTator, text mining | PubMed |
| Small Molecule Activators of Mitochondrial Fusion Prevent Congenital Heart Defects Induced by Maternal Diabetes. | JACC Basic Transl Sci | 2024 | 38559623 | PubTator, text mining | PubMed |
| Integrative bioinformatics analysis of miRNA and mRNA expression profiles and identification of associated miRNA-mRNA network in intracranial aneurysms. | Noncoding RNA Res | 2024 | 38511055 | PubTator, text mining | PubMed |
| MicroRNA copy number alterations in the malignant transformation of pleomorphic adenoma to carcinoma ex pleomorphic adenoma. | Head Neck | 2024 | 38482546 | PubTator, text mining | PubMed |
| [Retracted] MicroRNA‑140 represses glioma growth and metastasis by directly targeting ADAM9. | Oncol Rep | 2024 | 38456498 | PubTator, text mining | PubMed |
| Differential Expression of MicroRNA MiR-145 and MiR-155 Downstream Targets in Oral Cancers Exhibiting Limited Chemotherapy Resistance. | Int J Mol Sci | 2024 | 38396844 | PubTator, text mining | PubMed |
| A review on the role of KCNQ1OT1 lncRNA in human disorders. | Pathol Res Pract | 2024 | 38330620 | PubTator, text mining | PubMed |
| Advances in the role of GPX3 in ovarian cancer (Review). | Int J Oncol | 2024 | 38299269 | PubTator, text mining | PubMed |
| Synovial mesenchymal stem cell-derived exosomal miR-485-3p relieves cartilage damage in osteoarthritis by targeting the NRP1-mediated PI3K/Akt pathway: Exosomal miR-485-3p relieves cartilage damage. | Heliyon | 2024 | 38293485 | PubTator, text mining | PubMed |
| Reprogramming of glucose metabolism: Metabolic alterations in the progression of osteosarcoma. | J Bone Oncol | 2024 | 38288377 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406932/papers?page=4